Nanoparticle-mediated gene delivery to tumour neovasculature

Andrew R. Reynolds, S. Moein Moghimi, Kairbaan Hodivala-Dilke

Research output: Contribution to journalShort surveypeer-review

60 Scopus citations


The αvβ3 integrin is a potential pharmacological target for anti-angiogenic therapy. A recent report describes the use of αvβ3-targeted nanoparticles to deliver a gene to tumour vasculature selectively. This resulted in substantial tumour regression in several experimental mouse tumour models. Hence, this approach has great potential for the treatment of human cancer.

Original languageEnglish (US)
Pages (from-to)2-4
Number of pages3
JournalTrends in Molecular Medicine
Issue number1
StatePublished - Jan 1 2003

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology


Dive into the research topics of 'Nanoparticle-mediated gene delivery to tumour neovasculature'. Together they form a unique fingerprint.

Cite this